Clinical Trials in Detroit

Showing 18721-18740 of 19,719 trials

Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)

NCT00520234

Adults admitted to intensive care units are at risk for a variety of complications. Infections due to the fungus called candida are of particular concern. The study will test the possibility that caspofungin, a new therapy for fungal infections, can successfully reduce the rate of candida infections in subjects at risk. It will also test if caspofungin is useful in treating subjects for this disease when diagnosed using a new blood test that is performed twice weekly, permitting earlier diagnosis than current practice standards.

Invasive Candidiasis

Mycoses Study Group222 participantsStarted Aug 2007

Birmingham, Alabama, United States • Los Angeles, California, United States • Denver, Colorado, United States +9 more locations

COMPLETEDPhase 3< 1 mile

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

NCT00002429

This study tests a new form of didanosine, ddI EC, a coated pill that passes through the stomach before dissolving. The purpose of this study is to compare the effectiveness of an anti-HIV drug combination that includes ddI EC versus another anti-HIV drug combination.

HIV Infections

Bristol-Myers Squibb500 participantsStarted Jul 1999

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +20 more locations

Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Find Trials by Condition in Detroit

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer

International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Efficacy and Safety Study of XP12B in Women With Menorrhagia

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer

Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine